Company intelligence / Profile preview

Bioceramed

Ownership: Private
Employees: ~12
Development stage: Other

Overview

Bioceramed develops and manufactures class III medical devices and biomaterials for bone regeneration and related applications. Its products are CE marked, ISO 13485 certified, and sold in over 50 countries. The company is active in R&D collaborations with academic partners to develop new biomaterials for orthopedic, dental, spinal, peripheral nerve repair, and wound healing applications.

Therapeutic areas: NeurologyInfectious DiseasesOther
Modalities: DeviceBiomaterialDrug delivery
Industry: Implantable Medical Devices

Partnerships

Academic partnerships with universities/research institutes on multiple EU-funded projects[1][2]

Beyond the preview

Go deeper on Bioceramed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioceramed.

Explore the full profile